Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for TAL1
Z-value: 4.55
Motif logo
Transcription factors associated with TAL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TAL1
|
ENSG00000162367.7 | TAL bHLH transcription factor 1, erythroid differentiation factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TAL1 | hg19_v2_chr1_-_47697387_47697457 | 0.69 | 1.1e-05 | Click! |
Activity profile of TAL1 motif
Sorted Z-values of TAL1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_106781017 | 16.60 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
| chr2_-_89247338 | 13.54 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr22_+_22681656 | 13.39 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr14_-_106539557 | 13.27 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr22_+_22730353 | 12.91 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
| chr14_-_106758101 | 11.35 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
| chr22_+_23029188 | 10.80 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr22_+_23040274 | 10.64 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr14_-_106967788 | 10.48 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr14_-_106406090 | 10.39 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr22_+_23165153 | 10.36 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr14_-_106494587 | 10.31 |
ENST00000390597.2
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
| chr14_-_106312010 | 10.17 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
| chr14_-_106878083 | 10.04 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr14_-_106805716 | 10.03 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
| chr22_+_23222886 | 9.95 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
| chr14_-_106114739 | 9.83 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
| chr14_-_106478603 | 9.63 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
| chr14_-_106322288 | 9.56 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr14_-_106518922 | 9.37 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr22_+_23134974 | 9.07 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr14_-_107219365 | 9.01 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr16_+_23847339 | 8.69 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr14_-_107078851 | 8.66 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr7_+_142326335 | 8.49 |
ENST00000390393.3
|
TRBV19
|
T cell receptor beta variable 19 |
| chr14_-_107179265 | 8.27 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
| chr14_-_107131560 | 7.94 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
| chr16_+_32859034 | 7.53 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
| chr22_+_23077065 | 7.48 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr15_-_20170354 | 7.48 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr21_-_46330545 | 7.39 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr22_+_22453093 | 7.37 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
| chr2_+_89999259 | 7.29 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr2_+_89952792 | 7.21 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr2_-_89310012 | 7.21 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr14_-_107095662 | 7.15 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
| chr14_-_106791536 | 7.01 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
| chr7_+_142020496 | 6.90 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
| chr14_+_22314715 | 6.86 |
ENST00000390434.3
|
TRAV8-2
|
T cell receptor alpha variable 8-2 |
| chr22_+_23154239 | 6.76 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr14_-_106926724 | 6.73 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr22_+_23063100 | 6.69 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr14_-_106453155 | 6.66 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr2_+_90153696 | 6.62 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr2_-_89568263 | 6.62 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr7_-_38339890 | 6.55 |
ENST00000390341.2
|
TRGV10
|
T cell receptor gamma variable 10 (non-functional) |
| chr16_+_32077386 | 6.50 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr7_-_142181009 | 6.48 |
ENST00000390368.2
|
TRBV6-5
|
T cell receptor beta variable 6-5 |
| chr6_-_24911195 | 6.43 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
| chr7_-_142162390 | 6.38 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
| chr16_+_23847355 | 6.37 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
| chr16_+_33629600 | 6.36 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
| chr6_-_31560729 | 6.27 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
| chr15_-_22473353 | 6.24 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
| chr14_+_22362613 | 6.23 |
ENST00000390438.2
|
TRAV8-4
|
T cell receptor alpha variable 8-4 |
| chr22_+_23101182 | 6.22 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr12_+_6554021 | 6.21 |
ENST00000266557.3
|
CD27
|
CD27 molecule |
| chr22_+_22764088 | 6.18 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr4_+_74718906 | 6.04 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
| chr2_+_90139056 | 6.03 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr13_+_108922228 | 6.01 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
| chr2_-_89417335 | 5.98 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr7_-_142198049 | 5.96 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
| chr16_+_23847267 | 5.95 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr2_-_235405168 | 5.94 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr7_-_142247606 | 5.88 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
| chr6_+_6588316 | 5.86 |
ENST00000379953.2
|
LY86
|
lymphocyte antigen 86 |
| chr2_-_89513402 | 5.80 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr7_-_38394118 | 5.77 |
ENST00000390345.2
|
TRGV4
|
T cell receptor gamma variable 4 |
| chr2_-_158345462 | 5.74 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr2_+_89184868 | 5.73 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr7_-_142149390 | 5.72 |
ENST00000390372.3
|
TRBV5-5
|
T cell receptor beta variable 5-5 |
| chr17_-_39258461 | 5.69 |
ENST00000440582.1
|
KRTAP4-16P
|
keratin associated protein 4-16, pseudogene |
| chr16_+_28943260 | 5.66 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
| chr7_-_142240014 | 5.61 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
| chr22_+_23089870 | 5.61 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr21_+_10862622 | 5.61 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr22_+_22723969 | 5.60 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
| chr14_-_106552755 | 5.60 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
| chr14_+_22446680 | 5.56 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
| chr7_+_142428476 | 5.55 |
ENST00000390400.2
|
TRBV28
|
T cell receptor beta variable 28 |
| chr14_-_106471723 | 5.50 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr22_+_22385332 | 5.48 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr22_+_23010756 | 5.31 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
| chr2_-_89597542 | 5.30 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
| chr11_-_117698787 | 5.29 |
ENST00000260287.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr14_-_106725723 | 5.29 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr17_-_79623597 | 5.29 |
ENST00000574024.1
ENST00000331056.5 |
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma |
| chr19_-_50868882 | 5.29 |
ENST00000598915.1
|
NAPSA
|
napsin A aspartic peptidase |
| chr22_-_42322795 | 5.28 |
ENST00000291232.3
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C |
| chr2_-_87017985 | 5.26 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
| chr20_+_3776371 | 5.26 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
| chr14_-_107199464 | 5.19 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
| chr14_-_106586656 | 5.18 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
| chr15_-_22448819 | 5.15 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr8_+_56014949 | 5.14 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
| chr7_-_38398721 | 5.13 |
ENST00000390346.2
|
TRGV3
|
T cell receptor gamma variable 3 |
| chr14_+_22433675 | 5.05 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
| chr14_+_22386325 | 5.03 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr2_-_87018784 | 5.02 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
| chr14_+_98602380 | 5.02 |
ENST00000557072.1
|
RP11-61O1.2
|
RP11-61O1.2 |
| chr22_+_22930626 | 5.00 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr16_-_33647696 | 4.99 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr22_+_22516550 | 4.97 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
| chr11_+_118175132 | 4.96 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr14_-_107013465 | 4.95 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
| chr22_+_23247030 | 4.93 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr14_-_94856987 | 4.92 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr7_-_150497621 | 4.90 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
| chr4_-_165305086 | 4.88 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
| chr1_+_117297007 | 4.87 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr7_-_38403077 | 4.83 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
| chr7_+_142000747 | 4.82 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr14_-_106816253 | 4.81 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
| chr2_+_89923550 | 4.76 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chr3_-_112218378 | 4.76 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chr14_-_106642049 | 4.72 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr14_-_106209368 | 4.71 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr2_-_89278535 | 4.69 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr2_+_89998789 | 4.67 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr14_+_22771851 | 4.67 |
ENST00000390466.1
|
TRAV39
|
T cell receptor alpha variable 39 |
| chr22_+_23248512 | 4.65 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr14_-_107170409 | 4.62 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
| chr22_+_23264766 | 4.62 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr14_-_94856951 | 4.60 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr7_+_142045246 | 4.57 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
| chr7_-_38370536 | 4.55 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
| chr14_-_106830057 | 4.55 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr2_+_204732666 | 4.55 |
ENST00000295854.6
ENST00000472206.1 |
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4 |
| chr14_-_106866934 | 4.52 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
| chr17_+_6900201 | 4.51 |
ENST00000480801.1
|
ALOX12
|
arachidonate 12-lipoxygenase |
| chr7_+_142423143 | 4.49 |
ENST00000390399.3
|
TRBV27
|
T cell receptor beta variable 27 |
| chr14_-_106573756 | 4.47 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
| chr2_+_204732487 | 4.46 |
ENST00000302823.3
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4 |
| chr19_+_55085248 | 4.42 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| chr22_+_23161491 | 4.36 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
| chr4_-_74847800 | 4.35 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
| chr17_-_38721711 | 4.32 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
| chr2_-_89157161 | 4.32 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
| chr2_-_158345341 | 4.31 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr14_-_107114267 | 4.30 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr6_-_149806105 | 4.27 |
ENST00000389942.5
ENST00000416573.2 ENST00000542614.1 ENST00000409806.3 |
ZC3H12D
|
zinc finger CCCH-type containing 12D |
| chr22_+_22697537 | 4.22 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
| chr7_+_150026938 | 4.21 |
ENST00000343855.4
|
ZBED6CL
|
ZBED6 C-terminal like |
| chr2_-_87017948 | 4.21 |
ENST00000409781.1
|
CD8A
|
CD8a molecule |
| chrX_-_70331298 | 4.20 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
| chr14_-_94857004 | 4.19 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chrX_+_118892545 | 4.17 |
ENST00000343905.3
|
SOWAHD
|
sosondowah ankyrin repeat domain family member D |
| chr1_+_161677034 | 4.11 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
| chr22_+_23229960 | 4.09 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr17_-_73839792 | 4.05 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
| chr2_+_90211643 | 4.04 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr22_+_22550113 | 4.03 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr7_+_150497569 | 4.03 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
| chr7_+_150497491 | 4.02 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
| chr1_-_92951607 | 4.01 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
| chr14_+_22392209 | 3.99 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
| chr1_+_27668505 | 3.97 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
| chr1_+_207627575 | 3.96 |
ENST00000367058.3
ENST00000367057.3 ENST00000367059.3 |
CR2
|
complement component (3d/Epstein Barr virus) receptor 2 |
| chr1_-_169555779 | 3.95 |
ENST00000367797.3
ENST00000367796.3 |
F5
|
coagulation factor V (proaccelerin, labile factor) |
| chr2_+_114163945 | 3.95 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr21_-_46334186 | 3.94 |
ENST00000522931.1
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr15_+_81489213 | 3.93 |
ENST00000559383.1
ENST00000394660.2 |
IL16
|
interleukin 16 |
| chrX_+_78426469 | 3.89 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
| chr14_+_22320634 | 3.87 |
ENST00000390435.1
|
TRAV8-3
|
T cell receptor alpha variable 8-3 |
| chr2_-_89459813 | 3.87 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr11_+_128634589 | 3.81 |
ENST00000281428.8
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
| chr7_+_142028105 | 3.78 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
| chr16_+_30485267 | 3.78 |
ENST00000569725.1
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr17_-_80275466 | 3.78 |
ENST00000312648.3
|
CD7
|
CD7 molecule |
| chr14_-_107211459 | 3.77 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
| chr15_-_31521567 | 3.77 |
ENST00000560812.1
ENST00000559853.1 ENST00000558109.1 |
RP11-16E12.2
|
RP11-16E12.2 |
| chr1_-_167487758 | 3.76 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
| chr20_-_62493217 | 3.74 |
ENST00000601296.1
|
C20ORF135
|
C20ORF135 |
| chr1_+_200842083 | 3.71 |
ENST00000304244.2
|
GPR25
|
G protein-coupled receptor 25 |
| chr2_+_98330009 | 3.69 |
ENST00000264972.5
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa |
| chr22_+_22712087 | 3.67 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
| chr3_+_32433154 | 3.66 |
ENST00000334983.5
ENST00000349718.4 |
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7 |
| chr14_-_107049312 | 3.66 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr21_-_46340807 | 3.65 |
ENST00000397846.3
ENST00000524251.1 ENST00000522688.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr2_+_90198535 | 3.64 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr14_-_107035208 | 3.64 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
| chr16_-_88772670 | 3.63 |
ENST00000562544.1
|
RNF166
|
ring finger protein 166 |
| chr12_+_6898674 | 3.60 |
ENST00000541982.1
ENST00000539492.1 |
CD4
|
CD4 molecule |
| chr22_+_24823517 | 3.59 |
ENST00000496258.1
ENST00000337539.7 |
ADORA2A
|
adenosine A2a receptor |
| chr5_+_49962772 | 3.59 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr17_+_34538310 | 3.57 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
| chr7_-_142176790 | 3.57 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
| chr14_-_106331652 | 3.56 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
| chr3_+_45982401 | 3.56 |
ENST00000438735.1
|
CXCR6
|
chemokine (C-X-C motif) receptor 6 |
| chr19_-_54850417 | 3.55 |
ENST00000291759.4
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 |
| chr5_-_156569850 | 3.53 |
ENST00000524219.1
|
HAVCR2
|
hepatitis A virus cellular receptor 2 |
| chr1_-_202130702 | 3.53 |
ENST00000309017.3
ENST00000477554.1 ENST00000492451.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr11_-_117695449 | 3.52 |
ENST00000292079.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr1_-_161039647 | 3.51 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr2_+_89901292 | 3.51 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr1_-_160832490 | 3.50 |
ENST00000322302.7
ENST00000368033.3 |
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
| chr11_+_71846748 | 3.50 |
ENST00000445078.2
|
FOLR3
|
folate receptor 3 (gamma) |
| chr19_+_1065922 | 3.50 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr7_-_38389573 | 3.49 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
Network of associatons between targets according to the STRING database.
First level regulatory network of TAL1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 21.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 4.3 | 4.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 3.0 | 15.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 2.9 | 507.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 2.9 | 14.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 2.4 | 2.4 | GO:0043318 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 2.3 | 11.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 2.2 | 2.2 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 2.2 | 8.7 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 2.1 | 32.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 2.1 | 6.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 2.0 | 4.0 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 2.0 | 5.9 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 1.9 | 5.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.8 | 9.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.8 | 5.5 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 1.8 | 5.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 1.8 | 3.5 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.8 | 5.3 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.7 | 8.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.7 | 6.9 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 1.7 | 8.6 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 1.7 | 6.6 | GO:0002432 | granuloma formation(GO:0002432) |
| 1.5 | 9.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 1.4 | 4.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.4 | 1.4 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 1.4 | 1.4 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 1.4 | 4.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.3 | 4.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 1.3 | 5.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 1.3 | 4.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.3 | 7.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.3 | 2.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.3 | 7.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.3 | 3.8 | GO:0040010 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 1.2 | 3.6 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 1.2 | 9.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.1 | 6.8 | GO:0032571 | response to vitamin K(GO:0032571) |
| 1.1 | 4.5 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 1.1 | 2.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 1.1 | 3.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 1.1 | 7.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 1.1 | 9.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.1 | 4.3 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 1.1 | 6.3 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
| 1.0 | 4.2 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 1.0 | 2.0 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 1.0 | 5.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.0 | 10.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.0 | 7.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.0 | 2.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 1.0 | 1.0 | GO:0044060 | regulation of endocrine process(GO:0044060) |
| 1.0 | 2.9 | GO:0033214 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 1.0 | 20.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.9 | 6.6 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.9 | 3.7 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.9 | 196.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.9 | 5.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.9 | 5.3 | GO:0043366 | beta selection(GO:0043366) |
| 0.9 | 1.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.8 | 4.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.8 | 4.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 2.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.8 | 5.6 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.8 | 4.8 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.8 | 2.3 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.8 | 2.3 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 | 3.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.7 | 10.4 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.7 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.7 | 3.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.7 | 2.2 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.7 | 4.4 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.7 | 2.2 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.7 | 2.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.7 | 2.9 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.7 | 2.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.7 | 2.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.7 | 7.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.7 | 6.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.7 | 0.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
| 0.7 | 9.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.7 | 0.7 | GO:0045992 | negative regulation of embryonic development(GO:0045992) regulation of endodermal cell differentiation(GO:1903224) negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.7 | 2.7 | GO:0034255 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.7 | 2.0 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.7 | 0.7 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.7 | 2.0 | GO:0070054 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.7 | 4.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.7 | 1.3 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.7 | 1.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.7 | 1.3 | GO:0002434 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 0.7 | 4.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.7 | 1.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.6 | 1.3 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.6 | 1.9 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.6 | 2.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.6 | 2.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.6 | 1.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.6 | 1.9 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.6 | 2.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.6 | 1.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) pathway-restricted SMAD protein phosphorylation(GO:0060389) |
| 0.6 | 3.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.6 | 0.6 | GO:2000451 | positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
| 0.6 | 3.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 | 1.8 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.6 | 4.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.6 | 4.0 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.6 | 5.8 | GO:2001179 | regulation of interleukin-10 secretion(GO:2001179) |
| 0.6 | 0.6 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
| 0.6 | 4.0 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.6 | 0.6 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.6 | 11.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.6 | 4.0 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.6 | 3.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.6 | 6.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.5 | 3.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.5 | 2.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 | 2.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.5 | 1.6 | GO:2001226 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
| 0.5 | 14.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.5 | 0.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.5 | 6.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.5 | 4.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 1.6 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.5 | 3.1 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.5 | 3.1 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.5 | 1.0 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.5 | 5.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.5 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.5 | 0.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.5 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
| 0.5 | 2.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.5 | 2.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.5 | 1.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.5 | 2.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.5 | 2.0 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.5 | 6.0 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.5 | 1.5 | GO:0060490 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.5 | 1.4 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.5 | 0.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.5 | 1.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.5 | 2.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.5 | 2.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.5 | 1.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.5 | 3.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.5 | 3.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.5 | 1.4 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.5 | 1.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 | 3.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.5 | 0.5 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.5 | 0.9 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.5 | 34.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.5 | 4.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 10.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 | 1.8 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.5 | 4.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.5 | 1.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.5 | 0.9 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.5 | 1.4 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.5 | 1.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.4 | 0.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.4 | 1.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.4 | 2.7 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.4 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.4 | 5.4 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.4 | 2.7 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 | 2.7 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.4 | 7.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.4 | 0.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
| 0.4 | 2.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.4 | 1.3 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.4 | 5.1 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.4 | 1.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.4 | 2.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.4 | 3.4 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.4 | 1.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.4 | 0.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.4 | 2.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.4 | 1.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 | 3.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 | 4.1 | GO:0001554 | luteolysis(GO:0001554) |
| 0.4 | 0.4 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.4 | 3.6 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.4 | 4.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.4 | 20.4 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.4 | 5.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.4 | 0.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 2.0 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 | 3.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.4 | 1.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.4 | 7.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.4 | 2.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.4 | 1.2 | GO:0002352 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.4 | 1.2 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 0.4 | 1.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.4 | 131.7 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.4 | 7.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
| 0.4 | 1.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.4 | 1.1 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.4 | 0.4 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.4 | 2.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.4 | 2.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 | 0.7 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.4 | 5.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 0.4 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 1.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.4 | 1.8 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.4 | 3.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.4 | 1.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 | 1.8 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.4 | 1.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.4 | 1.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 | 0.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.3 | 2.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 0.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 3.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.3 | 1.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.3 | 0.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.3 | 6.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.3 | 0.7 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 | 3.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.3 | 1.3 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.3 | 3.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 19.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.3 | 2.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.3 | 1.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.3 | 3.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 4.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 1.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 | 10.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.3 | 33.5 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.3 | 1.3 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.3 | 1.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.3 | 4.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.3 | 0.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.3 | 1.6 | GO:1903282 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.3 | 1.3 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.3 | 0.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.3 | 0.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.3 | 1.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.3 | 1.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.3 | 1.5 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.3 | 1.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 26.0 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.3 | 0.3 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 0.3 | 0.3 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.3 | 2.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.3 | 0.9 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.3 | 0.6 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.3 | 2.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 3.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.3 | 2.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.3 | 1.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 0.9 | GO:1903464 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.3 | 0.9 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.3 | 1.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.3 | 1.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.3 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 1.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.3 | 2.0 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.3 | 0.9 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 | 3.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.3 | 0.8 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.3 | 0.8 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.3 | 2.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.3 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.3 | 4.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.3 | 2.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 | 1.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 | 1.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.3 | 2.7 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 | 2.4 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.3 | 0.5 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 | 2.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 2.4 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.3 | 0.8 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.3 | 2.6 | GO:0008228 | opsonization(GO:0008228) |
| 0.3 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.3 | 0.8 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
| 0.3 | 0.8 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.3 | 1.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.3 | 0.3 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.3 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 | 0.8 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.3 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 | 3.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 1.8 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 | 3.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 | 1.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 | 2.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.3 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 | 2.5 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.3 | 1.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.3 | 1.3 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.3 | 2.5 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.2 | 1.2 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.2 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 | 0.5 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.2 | 0.5 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.2 | 1.9 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 1.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.2 | 0.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 | 0.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.2 | 2.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 1.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.2 | 0.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 2.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 | 1.9 | GO:0090197 | regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.2 | 0.7 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.2 | 4.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.2 | 0.7 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 6.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.2 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.2 | 0.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.2 | 1.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 1.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 6.9 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.2 | 4.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 5.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.2 | 0.9 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 0.5 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.2 | 0.7 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.2 | 1.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.2 | 3.0 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 0.5 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.2 | 4.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 1.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 1.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 1.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 12.7 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.2 | 1.1 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.2 | 1.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 0.4 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.2 | 0.9 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.2 | 0.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 | 0.9 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.2 | 0.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 1.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.2 | 2.8 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.2 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
| 0.2 | 2.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 | 0.2 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.2 | 0.9 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 0.6 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 | 0.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 0.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.2 | 5.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 1.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 | 0.2 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.2 | 2.1 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.2 | 0.8 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 2.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.2 | 0.4 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.2 | 1.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.2 | 0.6 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.2 | 1.8 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.2 | 0.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.2 | 0.4 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
| 0.2 | 0.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 | 2.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 6.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.2 | 3.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 1.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.2 | 2.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 2.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.2 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 0.2 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
| 0.2 | 1.3 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.2 | 1.3 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 0.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 | 1.3 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) negative regulation of dendritic spine maintenance(GO:1902951) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.2 | 0.9 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.2 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.2 | 0.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
| 0.2 | 0.4 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.2 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 | 0.4 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 0.2 | 3.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 4.7 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 0.7 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.2 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.2 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.2 | 2.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 3.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.2 | 1.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 | 0.5 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
| 0.2 | 0.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.2 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.2 | 5.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.5 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.2 | 0.5 | GO:0009624 | response to nematode(GO:0009624) |
| 0.2 | 0.7 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.2 | 2.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
| 0.2 | 2.3 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 | 2.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 0.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 0.5 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.2 | 1.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.2 | 1.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.2 | 0.6 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.2 | 0.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 | 1.4 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.2 | 4.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 | 0.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.2 | 0.5 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 | 0.2 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.2 | 2.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.2 | 0.9 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 1.4 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.2 | 1.6 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 | 0.5 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.2 | 0.8 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.2 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 0.6 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.2 | 0.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 0.4 | GO:0050894 | determination of affect(GO:0050894) |
| 0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 1.3 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 | 1.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 1.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 0.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 1.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.7 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.1 | 0.3 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 1.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.7 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 2.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 4.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.6 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 1.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.1 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 | 0.8 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.1 | 2.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 1.7 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.1 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 1.9 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.1 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.1 | 0.3 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 | 1.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 0.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.1 | 0.3 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.1 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 0.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 3.9 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.7 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.1 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 1.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 | 3.2 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.1 | 12.2 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.1 | 1.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.1 | 1.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.6 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 3.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 0.3 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.1 | 0.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 | 1.9 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.5 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 1.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 3.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 1.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.1 | 1.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 1.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 3.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 4.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.4 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.1 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.4 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.1 | 1.3 | GO:0070231 | T cell apoptotic process(GO:0070231) |
| 0.1 | 0.4 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.1 | 3.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.7 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.4 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.1 | 0.7 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 1.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 | 1.2 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 1.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 | 1.0 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 1.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 1.1 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 6.0 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 0.6 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 2.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 1.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 0.3 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 | 0.3 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.1 | 0.2 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.1 | 1.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 | 0.2 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.1 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 0.1 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.1 | 0.2 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.1 | 1.0 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 1.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.1 | 0.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.1 | 1.5 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 2.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.1 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 0.2 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
| 0.1 | 1.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 0.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 1.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 | 0.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 1.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 1.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 2.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.8 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
| 0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.4 | GO:0071505 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) |
| 0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 3.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.1 | 1.9 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 0.9 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
| 0.1 | 0.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 0.6 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.5 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 0.1 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 2.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 2.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.3 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 | 3.2 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 5.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 | 1.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 0.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.1 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 1.2 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
| 0.1 | 1.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 1.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 | 4.3 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
| 0.1 | 0.5 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 4.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 1.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.1 | 0.8 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 | 2.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 3.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 0.1 | 2.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 2.5 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 53.2 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.3 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
| 0.1 | 1.6 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 2.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.1 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 3.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 | 3.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 1.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.3 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 0.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.1 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |